Neurocognitive testing: Clinical Trials

1 trial of Neurocognitive testing, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 recruiting. 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 31Recruiting 1

Follow Neurocognitive testing: new trials by email Literature Review of Neurocognitive testing trials Research Report on Neurocognitive testing

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Biomarker Exploration in Aging, Cognition and Neurodegeneration
Amyloid PET scan, Tau PET scan using MK-6240, Neurocognitive testing - Alzheimer Disease, Cognitive Impairment
Phase 3RecruitingUniversity of California, Irvine3002018-05-012026-01-23

Conditions studied

Alzheimer Disease (1)  ·  Cognitive Dysfunction (1)

Sponsors

University of California, Irvine (1)

Countries

United States (1)

Top investigators

Liv C McMillan, BS, CCRP (1)  ·  Michael A Yassa, PhD (1)

Results publications

PMID 31748377, PMID 32875052, PMID 34604910, PMID 36302636, PMID 37035460

NIH funding

R01AG053555 (1)